Core Viewpoint - Organigram Global Inc. has announced an expansion of its innovation investment in Phylos Bioscience Inc., reinforcing its leadership in seed-based cannabis genetics [1] Group 1: Company Developments - Organigram is recognized as Canada's 1 cannabis company by market share [1] - The company has secured priority access to Phylos' autoflower genetics pipeline through an amended loan and product agreement [1] - The new agreement includes preferential economic terms and long-term benefits for Organigram [1]